ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,673.41
-1.96%
S&P 500
5,222.09
0.01%
Dow Jones
39,418.33
-0.03%
US Dollar vs Yen
156.483
0.16%
Brent Oil
81.965
-1.50%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Acasti Pharma Inc (ACST)

  7. Acasti Pharma Inc (ACST) ニュース

ACST

Acasti Pharma (ACST)

Acasti Pharma Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ACST
日付受信時刻ニュースソース見出しコード企業名
2024/05/1105 : 11Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ACSTAcasti Pharma Inc
2024/05/1105 : 07Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ACSTAcasti Pharma Inc
2024/05/0908 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2024/05/0908 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2024/05/0908 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2024/05/0908 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2024/05/0908 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2024/02/1222 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACSTAcasti Pharma Inc
2024/02/1221 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACSTAcasti Pharma Inc
2024/01/0822 : 00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2024/01/0821 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACSTAcasti Pharma Inc
2023/12/2106 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2023/12/2106 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2023/12/2106 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2023/12/1521 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACSTAcasti Pharma Inc
2023/11/1321 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACSTAcasti Pharma Inc
2023/10/2405 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACSTAcasti Pharma Inc
2023/10/2101 : 23Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2023/10/1713 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACSTAcasti Pharma Inc
2023/10/1705 : 31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACSTAcasti Pharma Inc
2023/10/1205 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACSTAcasti Pharma Inc
2023/10/1020 : 40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ACSTAcasti Pharma Inc
2023/10/0705 : 30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ACSTAcasti Pharma Inc
2023/09/2808 : 46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2023/09/2621 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACSTAcasti Pharma Inc
2023/09/0604 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
2023/08/2606 : 01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ACSTAcasti Pharma Inc
2023/08/2605 : 21Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ACSTAcasti Pharma Inc
2023/08/2605 : 15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ACSTAcasti Pharma Inc
2023/08/1120 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACSTAcasti Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:ACST

最近閲覧した銘柄

AMEX
XLV
Health Care Select Sector
NASDAQ
AMZN
Amazon.com
FX
USDJPY
US Dollar vs Yen
AMEX
SPY
SPDR S&P 500
NASDAQ
AAPL
Apple
NYSE
VZ
Verizon Communications
AMEX
XLF
Financial Select Sector
FX
USDGBP
US Dollar vs Sterling
USOTC
DTEGY
Deutsche Telekom (QX)
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
GOOGL
Alphabet
CCOM
US30
US 30
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有